Consonance Capital Partners Invests in Orsini Pharmacy

We represented Consonance Capital Partners, a leading healthcare-focused private equity fund, in the recapitalization of Orsini Pharmaceutical Services, LLC, in partnership with the Company’s CEO and President, Michael Fieri.

Orsini is a leading rare disease specialty pharmacy differentiated by its personalized service and focus on complex conditions that require a high-touch patient journey. Financial terms of the transaction were not disclosed.

You Also May Be Interested In:

  • Representation of Family Legacy, LLC and Harpeth Hills Memory Gardens, Inc. in their sale to Park Lawn Corporation (TSX: PLC), a company that provides goods and services associated with the disposition and memorialization of human remains

    We represented Family Legacy, LLC and Harpeth Hills Memory Gardens, Inc. in their sale to Park Lawn Corporation (TSX: PLC),...
    Client Type: Private Company
  • Representation of WellCare Health Plans, Inc., a government-focused managed care provider, in its merger with Centene Corporation (NYSE: CNC) for $17.3 billion

    We represented WellCare Health Plans, Inc. in its merger with Centene Corporation (NYSE: CNC) for $17.3 billion. The combined company...
    Client Type: Public Company
  • Representation of LFM Capital in its sale of EDSCO Fasteners, a leading supplier of foundation anchoring systems for critical infrastructure installations, to MiddleGround Capital

    We represented LFM Capital in its sale of EDSCO Fasteners, a leading supplier of foundation anchoring systems for critical infrastructure...
    Client Type: Private Company